$TAYD
TAYLOR DEVICES, INC.

2025 Q1 Form 10-Q Financial Statement

#000137647425000012 Filed on January 03, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q4
Revenue $8.549M
YoY Change -17.32%
Cost Of Revenue $4.663M
YoY Change -15.67%
Gross Profit $3.886M
YoY Change -19.22%
Gross Profit Margin 45.46%
Selling, General & Admin $2.839M
YoY Change 6.21%
% of Gross Profit 73.06%
Research & Development $102.9K
YoY Change 22.41%
% of Gross Profit 2.65%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.942M
YoY Change 6.71%
Operating Profit $944.2K
YoY Change -54.02%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $307.9K
YoY Change -22.78%
Pretax Income $1.252M
YoY Change -48.94%
Income Tax $195.9K
% Of Pretax Income 15.65%
Net Earnings $1.056M
YoY Change -46.69%
Net Earnings / Revenue 12.35%
Basic Earnings Per Share $0.34
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 3.136M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2025 Q1 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.355M
Short-Term Investments
Other Short-Term Assets $2.100M
YoY Change 428.95%
Inventory $8.611M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $48.58M
YoY Change 1.29%
LONG-TERM ASSETS
Property, Plant & Equipment $11.32M
YoY Change -0.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $14.28M
YoY Change 6.0%
TOTAL ASSETS
Total Short-Term Assets $48.58M
Total Long-Term Assets $14.28M
Total Assets $62.86M
YoY Change 2.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $857.4K
YoY Change -26.59%
Accrued Expenses $2.497M
YoY Change -17.64%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.063M
YoY Change -1.99%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.063M
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $54.85M
YoY Change 19.35%
Common Stock $14.02M
YoY Change 23.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.08M
YoY Change 321.72%
Treasury Stock Shares
Shareholders Equity $55.80M
YoY Change
Total Liabilities & Shareholders Equity $62.86M
YoY Change 2.32%

Cashflow Statement

Concept 2025 Q1 2024 Q4
OPERATING ACTIVITIES
Net Income $1.056M
YoY Change -46.69%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-11-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-3498
dei Entity Registrant Name
EntityRegistrantName
Taylor Devices, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-0797789
dei Entity Address Address Line1
EntityAddressAddressLine1
90 Taylor Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
North Tonawanda
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14120
dei Entity Address Address Description
EntityAddressAddressDescription
Address of principal executive offices
dei City Area Code
CityAreaCode
716
dei Local Phone Number
LocalPhoneNumber
694-0800
dei Phone Fax Number Description
PhoneFaxNumberDescription
Registrant’s telephone number, including area code
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3136209 shares
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2355333 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2831471 usd
CY2024Q4 us-gaap Short Term Investments
ShortTermInvestments
24246282 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
28131279 usd
CY2024Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
8247705 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5212408 usd
CY2024Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
8610730 usd
CY2024Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
7512052 usd
CY2024Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
3017641 usd
CY2024Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
4356565 usd
CY2024Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2099632 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
725506 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
48577323 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
48769281 usd
CY2024Q4 us-gaap Other Inventory Noncurrent
OtherInventoryNoncurrent
1427583 usd
CY2024Q2 us-gaap Other Inventory Noncurrent
OtherInventoryNoncurrent
1579829 usd
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11318103 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11180933 usd
CY2024Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
281481 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
292593 usd
CY2024Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
244627 usd
CY2024Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
242167 usd
CY2024Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1012615 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1012615 usd
CY2024Q4 us-gaap Assets
Assets
62861732 usd
CY2024Q2 us-gaap Assets
Assets
63077418 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
857351 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1438847 usd
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2497496 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4664463 usd
CY2024Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
3707908 usd
CY2024Q2 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
5601274 usd
CY2024Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2024Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
126148 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7062755 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11830732 usd
CY2024Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14024605 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13063587 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
54849833 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
51127018 usd
CY2024Q4 us-gaap Treasury Stock Value
TreasuryStockValue
13075461 usd
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
12943919 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
55798977 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
51246686 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62861732 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63077418 usd
CY2024Q4 us-gaap Revenues
Revenues
8548881 usd
CY2023Q4 us-gaap Revenues
Revenues
10339875 usd
us-gaap Revenues
Revenues
20166737 usd
us-gaap Revenues
Revenues
20263503 usd
CY2024Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4662781 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5529208 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10777007 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11068260 usd
CY2024Q4 us-gaap Gross Profit
GrossProfit
3886100 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
4810667 usd
us-gaap Gross Profit
GrossProfit
9389730 usd
us-gaap Gross Profit
GrossProfit
9195243 usd
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
102922 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84081 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
172114 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
213155 usd
CY2024Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2838993 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2672926 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5368530 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5008883 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
944185 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2053660 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3849086 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3973205 usd
CY2024Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
307871 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
398688 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
684625 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
760006 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1252056 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2452348 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4533711 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4733211 usd
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195896 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
471000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
810896 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
904000 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
1056160 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1981348 usd
us-gaap Net Income Loss
NetIncomeLoss
3722815 usd
us-gaap Net Income Loss
NetIncomeLoss
3829211 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
55798977 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
54228325 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
55798977 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
54228325 usd
us-gaap Net Income Loss
NetIncomeLoss
3722815 usd
us-gaap Net Income Loss
NetIncomeLoss
3829211 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
833399 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
910956 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
11112 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
us-gaap Stock Option Down Round Feature Increase Decrease In Equity Amount1
StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1
-731204 usd
us-gaap Stock Option Down Round Feature Increase Decrease In Equity Amount1
StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1
-301308 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3035297 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1481404 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
946432 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1224268 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-1338924 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-2401673 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1374126 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-271607 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-581496 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-549722 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2293115 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1045751 usd
us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
-1893366 usd
us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
1013546 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
27343 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3486378 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7362621 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
970569 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
544801 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
2615003 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
7234549 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
6500000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2460 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2493 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2911968 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7781843 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
229814 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20875 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
131542 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
15799 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98272 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5076 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-476138 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-414146 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2831471 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3575219 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2355333 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3161073 usd
CY2024Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
844391 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
886947 usd
CY2024Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
7612075 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
6412497 usd
CY2024Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
217264 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
271608 usd
CY2024Q4 us-gaap Inventory Gross
InventoryGross
8673730 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
7571052 usd
CY2024Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
63000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
59000 usd
CY2024Q4 us-gaap Inventory Net
InventoryNet
8610730 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
7512052 usd
CY2024Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
43916 usd
CY2024Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
285689 usd
CY2024Q4 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
1897433 usd
CY2024Q2 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
3763777 usd
CY2024Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
556147 usd
CY2024Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
614997 usd
CY2024Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2497496 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4664463 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31

Files In Submission

Name View Source Status
0001376474-25-000012-index-headers.html Edgar Link pending
0001376474-25-000012-index.html Edgar Link pending
0001376474-25-000012.txt Edgar Link pending
0001376474-25-000012-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tayd-20241130.htm Edgar Link pending
tayd-20241130.xsd Edgar Link pending
td_ex31z1.htm Edgar Link pending
td_ex31z2.htm Edgar Link pending
td_ex32z1.htm Edgar Link pending
td_ex32z2.htm Edgar Link pending
tayd-20241130_def.xml Edgar Link unprocessable
tayd-20241130_cal.xml Edgar Link unprocessable
tayd-20241130_lab.xml Edgar Link unprocessable
tayd-20241130_pre.xml Edgar Link unprocessable
tayd-20241130_htm.xml Edgar Link completed